Abstract
Objective
To evaluate the effects of intravenous of zidovudine (AZT) at a dose and duration of infusion comparable to that used clinically on parameters reflective of fetal well-being.
Methods
Tliirteen chronically instrumented noninfected baboons were monitored during intravenous infusions of AZT. Fetal cardiorespiratory activity and neurobehavioral function were assessed with 4—48-hour infusion of AZT to ten mothers (0.5-2.1 mg/kg per hour) and three fetuses (2-6 mg/h), which resulted in fetal plasma concentrations of AZT of 194—3100 ng/ml.
Results
No significant differences were found in the mean values in control periods, before and after infusion with values during infusion for parameters of fetal heart rate and rate variability (n = 7), breathing activity (n = 8), electroencephalographic activity (n = 8), and behavioral state (n = 7). No correlations were found with drug level.
Conclusions
The absence of associations between exposure of the fetal baboon to AZT and changes in parameters reflective of fetal condition suggests that comparable exposure of the human fetus during intravenous infusion of drug would not confound clinical monitoring used to assess fetal well-being. These findings supplement conclusions from clinical research in support of U.S. Public Health Service recommen-dations that intrapartum fetal monitoring be performed as clinically indicated, not specifically because pregnant patients are treated with intravenous AZT. (J Soc Gynecol Invest 1997;4:183-190) Copyright © 1997 by the Society for Gynecologic Investigation.
Similar content being viewed by others
References
Connor EM, Sperling RS, Gelber R, et al. Reduction of ma-ternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994;331:1173–80.
Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 1994;43:1–20.
Connor EM, Mofenson LM. Zidovudine for the reduction of perinatal human immunodeficiency virus transmission: Pediatric AIDS clinical trials group protocol 076 results and treatment recommendations. Pediatr Infect Dis J 1995;14:536–41.
Connor E, Sperling R, Shapiro D, et al. Long term effects of zidovudine (ZDV) exposure among uninfected infants born to HIV-infected mothers in ACTG protocol 076. Prog Abst ICAAC 1995:11,205.
Garland M, Szeto HH, Daniel SS, Tropper P, Myers MM, Stark RI. Zidovudine kinetics in the pregnant baboon. J Acquir Im-mune Defic Syndr 1996;11:117–27.
Manning FA. Fetal medicine principles and practice. Norwalk, CT: Appleton and Lange, 1995.
Domanski MJ, Sloas MM, Follmann DA, Scalise PP 3rd, Tucker EE, Egan D, Pizzo PA. Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus. J Pediatr 1995;127:137–46.
Mofenson LM. A critical review of studies evaluating the rela-tionship of mode of delivery to perinatal transmission of human immunodeficiency virus. Pediatr Infect Dis J 1995;14:169–77.
Peckham C, Gibb D. Mother-to-child transmission of the human immunodeficiency virus. N Engl J Med 1995;333:298–302.
Stark RI, Daniel SS, James LS, et al. Chronic instrumentation and longterm investigation in the fetal and maternal baboon: Tether system, conditioning procedures and surgical techniques. Lab Animal Sci 1989;39:25–32.
Myers MM, Fifer W, Haiken J, Stark RI. Relationships between breathing activity and heart rate in fetal baboons. Am J Physiol 1990;258:R1479–85.
Myers MM, Stark RI, Fifer WP, et al. A quantitative method for classification of EEG in the fetal baboon. Am J Physiol 1993;265: R706–14.
Stark RI, Daniel SS, Kim YI, Leung K, Rey HR, Tropper PJ. Patterns of development in fetal breathing activity in the latter third of gestation of the baboon. Early Hum Develop 1993;32:31–47.
Stark RI, Daniel SS, Garland M, et al. Fetal hiccups in the baboon. Am J of Physiol 1994;267:R1479–87.
Grieve PG, Myers MM, Stark RI. Behavioral states in the fetal baboon. Early Hum Develop 1994;39:159–75.
Fletcher KL, Leung K, Myers MM, Stark RI. Diurnal rhythms in cardiorespiratory function of the fetal baboon. Early Hum Develop 1996;46:27–42.
Editorial. Zidovudine for mother, fetus, and child: Hope or poison? Lancet 1994;344:207–9.
O’Sullivan MJ, Boyer PJJ, Scott GB, et al. The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: Phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Am J Obstet Gynecol 1993;168:1510–6.
Lipshultz SE, Orav EJ, Sanders SP, Hale AR, Mcintosh K, Colan SD. Cardiac structure and function in children with human immunodeficiency virus infection treated with zidovudine. N Engl J Med 1992;327:1260–5.
Pindado MTC, Bravo AL, Martinez-Rodriguez R, et al. Histo-chemical and ultrastructural changes induced by zidovudine in mitochondria of rat cardiac muscle. Eur J Histochem 1994;38:311–8.
Lewis W, Simpson JF, Meyer RR. Cardiac mitochondrial DNA polymerase-gamma is inhibited competitively and noncompeti-tively by phosphorylated zidovudine. Circ Res 1994;74:344–8.
Dawes G, Meir YJ, Mandruzzto GP. Computerized evaluation of fetal heart-rate patterns. J Perinatal Med 1994;22(6):491–9.
Vintzileos AM, Knuppel RA. Multiple parameter biophysical testing in the prediction of fetal acid-base status. Clinics in Perinatol 1994;21:823–48.
Hooper SB. Fetal metabolic responses to hypoxia. Reproduc Fertil Devel 1995;7(3):527–38.
Albrecht H, Stellbrink HJ. Hiccups in people with AIDS [letter]. J Acquir Immune Defic Syndr 1994;7: 735.
Nozyce M, Hittelman J, Muenz L, Durako SJ, Fischer ML, Willoughby A. Effect of perinataUy acquired human immunodeficiency virus infection on neurodevelopment in children during the first two years of life. Pediatr 1994;94:883–91.
Chase C, Vibbert M, Pelton SI, Coulter DL, Cabral H. Early neurodevelopmental growth in children with vertically transmitted human immunodeficiency virus infection. Arch Pediatr Ado-lesc Med 1995;149:850–5.
Holmes GL, Lombroso CT. Prognostic value of background patterns in the neonatal EEG. J Clin Neurophysiol 1993;10:323–52.
Myers MM, Schulze KS, Fifer WP, Stark RI. Methods for quantifying state specific patterns of EEG activity in fetal baboons and immature human infants. In: Lecanuet JP, Fifer WP, Krasnegor NA, Smotherman WP, eds. Fetal behavior: A psychobio-logical perspective. Hillsdale, New Jersey, Earlbaum, 1994:35–49.
Bocking AD. Fetal behavioral states: Pathological alteration with hypoxia. Seminars in Perinatology 1992;16(4):252–7.
Author information
Authors and Affiliations
Additional information
Supported by the National Institute of Allergy and Infectious Diseases, grant no. AI 32314 and the National Institute of Child Health and Human Development, grant no. HD 13063.
We wish to thank Burroughs Wellcome for the zidovudine used in this study and Mr. T. Cooper, New York State Psychiatric Institute, for carrying out the zidovudine assay.
Rights and permissions
About this article
Cite this article
Stark, R.I., Garland, M., Daniel, S.S. et al. Fetal Cardiorespiratory and Neurobehavioral Response to Zidovudine (AZT) in the Baboon. Reprod. Sci. 4, 183–190 (1997). https://doi.org/10.1177/107155769700400403
Published:
Issue Date:
DOI: https://doi.org/10.1177/107155769700400403